PT  - JOURNAL ARTICLE
AU  - Kannan, Dwarakesh
AU  - Gurusriram, R
AU  - Banerjee, Rudra
AU  - Bhattacharjee, Srijit
AU  - Varadwaj, Pritish Kumar
TI  - Will there be a third COVID-19 wave? A SVEIRD model based study of India’s situation
AID  - 10.1101/2021.05.16.21257300
DP  - 2021 Jan 01
TA  - medRxiv
PG  - 2021.05.16.21257300
4099  - http://medrxiv.org/content/early/2021/05/18/2021.05.16.21257300.short
4100  - http://medrxiv.org/content/early/2021/05/18/2021.05.16.21257300.full
AB  - Since first patient detected in India in late February, 2020, SARS-CoV-II virus is playing havoc on India. After the first wave, India is now riding the 2nd wave. As was in the case of European countries like Italy and UK, the 2nd wave is more contagious and at the time of writing this paper, the per day infection is as high as 400,000. The alarming thing is it is not uncommon that people is getting infected multiple time. On the other hand, mass vaccination has started step by step. There is also growing danger of potential 3rd wave is unavoidable, which can even infect kids and minors.In this situation, an estimation of the dynamics of SARS-CoV-2 is absolutely necessary to combat the pandemic. We have used a modified SEIRD model, that includes vaccination and repeat infection as well. We have studied India and 8 Indian states with varying SARS-CoV-2 infection. We have shown that, Covid-19 wave will be repeated time to time, but the intensity will slow down with time. In most possible situation, our calculation shows COVID-19 will remain as endemic for foreseeable future, unless we are able to increase our vaccination rate manifold.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNo third party grantAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:I have the right to post this manuscript and confirm that all authors have assented to posting of the manuscript. All relevant ethical guidelines have been followed. All necessary patient/participant consent has been obtained. No clinical trials involved. I have followed all appropriate research reporting guidelines. I am legally responsible for the content of the article.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesNo human data used. Data source is cited properly.